title: Reliability of sentinel lymph node mapping with biopsy for head and neck cutaneous melanoma.
abstract: OBJECTIVE
  To determine (1) the reliability of sentinel lymph node mapping with biopsy (SLNB) in head and neck cutaneous melanoma to accurately stage nodal basins and (2) the safety of SLNB in both the neck and parotid regions.
  
  
  METHODS
  Retrospective cohort study with a median follow-up of 25 months. All patients had a minimum follow-up of 1 year.
  
  
  METHODS
  Academic medical center.
  
  
  METHODS
  Eighty evaluable patients diagnosed as having head and neck cutaneous melanoma and staged using SLNB.
  
  
  METHODS
  Sentinel lymph nodes were identified using preoperative lymphoscintigraphy and a combination of intraoperative gamma probe and isosulfan blue dye. Patients with a SLN positive for melanoma underwent therapeutic lymphadenectomy followed by an evaluation for adjuvant therapies. Patients with a negative SLNB result were followed up clinically.
  
  
  METHODS
  Percentage of positive SLNs, regional recurrence in the setting of a negative SLNB result (false-negative rate), and procedure complications.
  
  
  RESULTS
  The mean Breslow depth was 2.35 mm. A SLN was identified in 77 (96.3%) of cases, with an average of 2.18 nodes per patient. Of the sentinel nodes identified, 74% were from the neck region. The remaining 26% were from the parotid basin. No facial nerve complications occurred. Of the patients, 14 (18%) were SLN positive for metastatic melanoma. The regional failure rate in the setting of a negative SLNB result was 4.5%.
  
  
  CONCLUSIONS
  Sentinel lymph node mapping with biopsy is a reliable technique to diagnose regional spread from head and neck cutaneous melanoma. This procedure can be performed in both neck and parotid nodal basins with safety and accuracy similar to non-head and neck sites.
authors.affiliation: Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, MI 48109-0312, USA.
authors.forename: Cecelia E
authors.initials: CE
authors.lastname: Schmalbach
authors.forename: Brian
authors.initials: B
authors.lastname: Nussenbaum
authors.forename: Riley S
authors.initials: RS
authors.lastname: Rees
authors.forename: Jennifer
authors.initials: J
authors.lastname: Schwartz
authors.forename: Timothy M
authors.initials: TM
authors.lastname: Johnson
authors.forename: Carol R
authors.initials: CR
authors.lastname: Bradford
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D005260:Female; D006258:Head and Neck Neoplasms / Q000473:pathology*; D006801:Humans; D008297:Male; D008545:Melanoma / Q000473:pathology*; D008875:Middle Aged; D009367:Neoplasm Staging; D015203:Reproducibility of Results; D012189:Retrospective Studies; D021701:Sentinel Lymph Node Biopsy